Bico's Biosero Secures Major Contract Worth 143.6 Million SEK
Bico's subsidiary Biosero has secured a 143.6 million SEK contract with a global pharmaceutical firm.
- • Biosero signed a framework agreement in August 2025.
- • First purchase orders total 15.2 million dollars.
- • Contract highlights Bico's growth in laboratory automation.
- • Announcement made via press release.
Key details
Biosero, a subsidiary of Bico, has landed a significant framework agreement with a prominent global pharmaceutical company. Announced on September 5, 2025, the deal showcases Biosero's growing footprint in integrated laboratory automation solutions. Initially, this agreement has led to purchase orders aggregating approximately 15.2 million dollars, which is around 143.6 million Swedish kronor. This development signals Bico's capability to attract lucrative contracts within the competitive pharmaceutical industry, reinforcing the importance of its operations in the biotechnology sector.
This article was translated and synthesized from Swedish sources, providing English-speaking readers with local perspectives.
Source articles (1)
Latest news
Midsummer 2026 Marked by Violence, Disturbances, and Rare Outdoor Rape in Sweden
Dutch Team Faces Injury Woes and Apprehension Ahead of 2026 World Cup Clash with Sweden
Sweden Eyes Strong World Cup Run After Thrashing Tunisia, Faces Tough Battle Against Netherlands
Professor Francis J. Gavin Advocates Historical Insight to Enhance Political Decision-Making
Sweden Tightens Parental Benefit Fraud Sanctions Amid Debate on Political Morality and Politician's Conviction for Threats
Swedish Economy Set for Strong Recovery in Late 2026 Amid Steady Riksbank Interest Rates
The top news stories in Sweden
Delivered straight to your inbox each morning.